Myomo Reports Fourth Quarter and Full Year 2022 Financial Result
Myomo, Inc., a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced financial results for the three months and full year ended December, 31, 2022. inancial and operational highlights for the fourth quarter of 2022 include the following: Product and total revenues were $4.0 million, up 2% sequentially and similar to the prior year quarter; Revenue units were 101, up 16% sequentially and down 6% compared with the prior year quarter; MyoPro® orders and insurance authorizations were received for 98 patients, down 6% compared with the prior year quarter. Read more >>